SVS Guidelines Bundle

Management of Diabetic Foot

SVS GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/1309720

Contents of this Issue

Navigation

Page 1 of 11

2 Key Points ➤ Diabetes is one of the leading causes of chronic disease and limb loss worldwide, currently affecting 382 million people. ➤ Every year, >1 million people with diabetes suffer limb loss as a result of diabetes. ➤ Approximately 80% of diabetes-related lower extremity amputations are preceded by a foot ulcer. ➤ This progression from foot ulcer to amputation lends to several possible steps where intervention based on evidence-based guidelines may prevent major amputation. Prevention Prevention of Diabetic Foot Ulceration ➤ We recommend that patients with diabetes undergo annual interval foot inspections by physicians (MD, DO, DPM) or advanced practice providers with training in foot care (1C). ➤ We recommend that foot examination include testing for peripheral neuropathy using the Semmes-Weinstein test (1B). ➤ We recommend education of the patients and their families about preventive foot care (1C). Therapeutic Footwear: • We suggest against the routine use of specialized therapeutic footwear in average- risk diabetic patients (2C). • We recommend using custom therapeutic footwear in high-risk diabetic patients, including those with significant neuropathy, foot deformities, or previous amputation (1B). ➤ We suggest adequate glycemic control (hemoglobin A1c <7% with strategies to minimize hypoglycemia) to reduce the incidence of diabetic foot ulcers (DFUs) and infections, with subsequent risk of amputation (2B). ➤ We recommend against prophylactic arterial revascularization to prevent DFU (1C).

Articles in this issue

Archives of this issue

view archives of SVS Guidelines Bundle - Management of Diabetic Foot